期刊文献+

人脐血CD34^+细胞在NOD/SCID小鼠体内重建体液免疫的实验研究

Reconstitution of Humoral Immunity by the Transplantation of Human Umbilical Cord Blood CD34^+ Cells into NOD/SCID Mice
原文传递
导出
摘要 目的探讨人脐血CD34+造血干细胞(HSC)在NOD/SCID小鼠模型体内体液免疫功能重建的作用。方法从新鲜脐血中分离出单个核细胞(MNC),利用免疫磁珠分选法筛选CD34+造血干细胞,经尾静脉输注入经亚致死剂量照射的NOD/SCID小鼠体内,移植后4、6、8、10周分批处死存活的小鼠,取其脾脏和外周血,分别进行细胞表型分析、体液免疫分析,监测小鼠体液免疫功能重建情况。结果照射2周后,阴性对照组小鼠全部死亡,6周后移植组小鼠存活率为37.5%,空白对照组小鼠存活率为100%。移植4、6、8、10周移植组外周血人CD45+细胞表达(%)分别为4.87±1.23、9.22±2.07、12.34±2.38、8.14±2.36,CD19+B淋巴细胞表达(%)分别为1.07±0.50、2.17±0.95、3.34±0.90、1.67±0.90。移植后10周,在移植组小鼠脾脏可见CD19+B淋巴细胞分布。结论经照射后的NOD/SCID小鼠通过人脐血CD34+细胞植入可建立起人鼠嵌合免疫模型。缺少相应细胞因子刺激,CD34+细胞分化能力随时间减弱。 Objective To investigate the immune reconstitution by the transplantation of human umbilical cord blood CD34+ cells in the NOD/SCID mouse.Methods Mononuclear cells(MNC) were isolated from human fresh cord blood and CD34+ hematopoietic stem cells were selected by magnetic activated cell sorting method.The selected cells were transplanted via tail vein injection into 16 NOD/SCID mice after sublethal whole-body irradiation.Four mice were sacrificed respectively at 4th,6th,8th and 10th week after the transplantation,the harvested spleen and peripheral blood cells were used to cell phenotype analysis and humoral immune analysis,respectively.There were 14 mice in another two groups,7 mice did not receive the transplantation after irradiation,7 were used as blank control(no irradiation,no transplantation).Results The mice without transplantation all died within 2weeks after irradiation.The survival rate of the mice with transplantation was 37.5% at 6th week after the irradiation,while the survival rate of blank control was 100%.At 4th,6th,8th and 10th week,the percentage of human CD45+ cells in transplantation group were 4.87±1.23,9.22±2.07,12.34±2.38,8.14±2.36,respectively,and the percentage of CD19+ B lymphocytes were 1.07±0.50,2.17±0.95,3.34±0.90,1.67±0.90,respectively.10 weeks after the transplantation,human CD19+ B lymphocytes distribution were found in the transplanted mice spleen.Conclusion The human-mouse chimeric immune model can be built in irradiated NOD/SCID mice by the transplantation of human cord blood CD34+ cells.CD34+ cell differentiation declined with time,which might be due to the lack of appropriate cytokines.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期24-27,共4页 Journal of Sichuan University(Medical Sciences)
基金 贵州省科技厅(黔科合计2008-1003) 遵义市"15851"人才工程项目(市15851人才办2008-9) 贵州省教育厅培育项目(黔科教2009-113)资助
关键词 人脐血 NOD/SCID小鼠 CD34+干细胞 免疫重建 Human umbilical cord blood NOD/SCID mice CD34+ stem cell Immune reconstitution
  • 相关文献

参考文献12

  • 1Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature, 1983; 301 (5900) : 527-530.
  • 2Chang NH, Inman RD, Dick IE, et al. Bone marrow-derived human hematopoietic stem cells engraft NOD/SCID mice and traffic appropriately to an inflammatory stimulus in the joint. J Rheumatol, 2010; 37(3) : 496-502.
  • 3Salles 1L, Thijs T, Brunaud C, et al. Human platelets produced in nonobese diabetic/ severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34^+ cells are functionally active in an ex vivo flow model of thrombosis. Blood, 2009; 114 (24): 5044- 5051.
  • 4Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol,2005;33(10):1249-1256.
  • 5Andre MC, Erbacher A, Gille C, et al . Long-term human CD34^+ stem cell-engrafted nonobese diabetic/SCID/IL-2mull mice show impaired CD8^+ T cell maintenance and a functional arrest of immature NK cells. J Immunol , 2010; 185 ( 5) : 2710- 2720.
  • 6van Hensbergen Y, Schipper LF, Brand A, et al . Ex vivo culture of human CD34 + cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol, 2006; 34 (7) : 943-950.
  • 7莫文健,毛平,何秋山,应逸,朱志刚,许艳丽,杜庆华.无血清脐血巨核系祖细胞体外扩增的研究[J].中国实验血液学杂志,2004,12(2):133-137. 被引量:13
  • 8王雄国.干细胞研究及其在临床医学上的应用[J].生物学通报,2004,39(6):23-25. 被引量:6
  • 9Shultz LD, Saito Y, Najima Y, et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rnull humanized mice. PNAS, 2010; 107 (29) : 13022-13027.
  • 10Notta F, Doulatov S, Dick J E. Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/ IL-2Rgcnull recipients. Blood,2010;115(l8) :3704-3707.

二级参考文献19

  • 1Tao H, Gaudry L, Rice A, et al. Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol,1999;27:293-301
  • 2Schatmer M, Lefebvre P, Mingolelli SS, et al. Thrombopoietinstimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells,1996;14:207-214
  • 3van den Oudenrijn S, von dcm Borne AE, de Haas M. Influence of medium components on ex vivo megakaryocyte expansion. J Hematother Stem Cell Res,2001;10:193-200
  • 4Lefebvre P, Winter JN, Kahn LE, et al. Megakaryocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium. J Hematother,1999;8:199-208
  • 5Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood,2002;
  • 6Watts MJ, Somervaille TC, Ings SJ, et al. Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. BrJ Haematol,2002;118:117-123
  • 7Lazzari L, Henschler R, Leechi L, et al. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+megakaryocytic cells. Haematologica,2000;85:25-30
  • 8van den Oudenrijn S, von dem Bome AE, de Haas M. Differences in megakaryocyte expansion potential between CD34 + stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol,2000;28:1054-1061
  • 9Mwarmtemi HH, Higuchi T, Sawai N, et al. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow. Transplantation,2000;69:1645-1654
  • 10Bruno S, Gunetti M, Gammaitoni L, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.Haematologica,2003;88:379-387

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部